Changes to the cardiac biomarkers of non-elite athletes completing the 2009 London Marathon

Emergency Medicine Journal

Volumn 31, Issue 5, 2014, Pages 374-379

  Baker, Polly ^a   Davies, Sarah Louise ^b   Larkin, Joanne ^c   Moult, Daniel ^d   Benton, Sally ^e   Roberts, Andrew ^a   Harris, Timothy ^f  

^a Defence Medical Rehabilitation Centre   (United Kingdom)

^b ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e ROYAL LONDON HOSPITAL   (United Kingdom)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; TROPONIN I; TROPONIN T; BIOLOGICAL MARKER; TROPONIN;

ARTICLE; BLOOD SAMPLING; COLLAPSE; ENDURANCE; FOLLOW UP; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MARATHON RUNNER; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STRUCTURAL HEART DISEASE; UNITED KINGDOM; ADULT; BLOOD; CASE CONTROL STUDY; COHORT ANALYSIS; PHYSIOLOGY; RUNNING; SHOCK;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; HEART DISEASES; HUMANS; LONDON; NATRIURETIC PEPTIDE, BRAIN; PHYSICAL ENDURANCE; RUNNING; SHOCK; TROPONIN;

EID: 84901692183     PISSN: 14720205     EISSN: 14720213     Source Type: Journal    
DOI: 10.1136/emermed-2012-201465     Document Type: Article

References (24)

1. Fortescue EB, Shin AY, Greenes DS, et al . Cardiac troponin increases among runners in the Boston Marathon. Ann Emerg Med 2007;49:137-43.
2. George K, Whyte G, Stephenson C, et al . Postexercise left ventricular function and cTnT in recreational marathon runners. Med Sci Sports Exerc 2004;36:1709-15. (Pubitemid 39332288)
3. Herrmann M, Scharhag J, Miclea M, et al. Post-race kinetics of cardiac troponin T and I and N-terminal pro-brain natriuretic peptide in marathon runners. Clin Chem 2003;49:831-4. (Pubitemid 36513272)
4. Middleton N, Shave R, George K, et al. Impact of repeated prolonged exercise bouts on cardiac function and biomarkers. Med Sci Sports Exerc 2007;39:83-90. (Pubitemid 46095803)
5. Neilan TG, Januzzi JL, Lee-Lewandrowski E, et al. Myocardial Injury and ventricular dysfunction related to training levels among non-elite participants in the Boston marathon. Circulation 2006;114:2325-33. (Pubitemid 44847449)
6. Ohba H, Takada H, Musha H, et al. Effects of prolonged strenuous exercise on plasma levels of atrial natruiretic peptide and brain natruiretic peptide in healthy men. Am Heart J 2001;141:751-8. (Pubitemid 32378483)
7. Scharhag J, Urhausen A, Schneider G, et al. Reproducibility and clinical significance of exercise-induced increases in cardiac troponins and N-terminal pro-brain natriuretic peptide (NT-proBNP) in endurance athletes. Eur J Cardiovasc Prev Rehabil 2006;13:388-97. (Pubitemid 44318650)
8. Siegal AJ, Lewandrowski EL, Chun KY, et al. Changes in cardiac markers including B-natriuretic peptide in runners after the Boston marathon. Am J Cardiol 2001;88:920-3. (Pubitemid 32995937)
9. Tulloch L, Robinson D, Patel A, et al. Raised troponin T and echocardiographic abnormalities after prolonged strenuous exercise - the Australian Ironman Triathlon. Br J Sports Med 2006;40:605-9. (Pubitemid 44032645)
10. Vidotto C, Tschan H, Atamaniuk J, et al. Responses of N-terminal pro-brain natriuretic peptide (NT-proBNP) and cardiac troponin I (cTnI) to competitive endurance exercise in recreational athletes. Int J Sports Med 2005;26:645-50. (Pubitemid 41426814)
11. Whyte G, George K, Sharma S, et al. Cardiac fatigue following prolonged endurance exercise of differing distances. Med Sci Sports Exerc 2000;32:1067-72. (Pubitemid 30390268)
12. Jassal DS, Moffat D, Krahn J, et al. Cardiac injury markers in non-elite runners. Int J Sports Med 2009;30:75-9.
13. Siegel AJ, Januzzi J, Sluss P, et al. Cardiac biomarkers, electrolytes, and other analytes in collapsed marathon runners: implications for the evaluation of runners following competition. Am J Clin Pathol 2008;129:948-51.
14. http://www.activenetwork.com/about-us/press-room/press-releases/ 2011-press-releases/active-network-tracks-surge-in-US-running-event- participation.htm (accessed Apr 2012).
15. Aagaard P, Sahlen A, Braunschweig F. Performance trends and associations with biomarkers in a 30 km cross-country race. Med Sci Sports Exerc 2011;44:894-9.
16. Roberts WO. Exercise-associated collapse care matrix in the marathon. Sports Med 2007;37:431-3. (Pubitemid 46698558)
17. Roberts WO. A 12-yr profile of medical injury and illness for the Twin Cities Marathon. Med Sci Sports Exerc 2000;32:1549-55.
18. Holtzhausen LM, Noakes TD. The prevalence and significance of post-exercise (postural) hypotension in ultramarathon runners. Med Sci Sports Exerc 1995;27:1595-601.
19. Eijsvogels T, George K, Shave R, et al . Effect of prolonged walking on cardiac troponin levels. Am J Cardiol 2010;105:267-72.
20. Maisel A. The coming of age of natriuretic peptides: the emperor does have clothes! J Am Coll Cardiol 2006;47:61-4. (Pubitemid 43005165)
21. Reed MJ, Newby DE, Coull AJ, et al. Role of brain natriuretic peptide (BNP) in the risk stratification of adult syncope. Emerg Med J 2007;24:769-73. (Pubitemid 350055174)
22. Scharhag J, George K, Shave R, et al. Exercise-associated increases in cardiac biomarkers. Med Sci Sports Exerc 2008;40:1408-15.
23. Neilan T, Januzzi J, Lee-Lewandrowski E, et al. Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston Marathon. Circulation 2006;114:2325-33. (Pubitemid 44847449)
24. Fortescue E, Shin A, Greenes D, et al. Cardiac troponin increases among runners in the Boston Marathon. Ann Emerg Med 2007;49:137-43.